
Obesity Studies Melbourne (E)
Sunshine Melbourne
Struggling with excess weight?
You may be eligible to join a clinical research study evaluating an investigational treatment for weight management.
Researchers are studying the safety and tolerability of the investigational treatment, its effects on blood sugar and other health markers and whether it may help support weight reduction over time.
If you have struggled to lose weight, with or without Type 2 Diabetes, you may be eligible to take part.
Description
What to expect
Ages
18 years or older
Duration
The study duration is approximately up to 2.5 years and includes clinic visits every 4-12 weeks and regular phone calls.
Compensation
Eligible participants will be reimbursed
Eligibility Criteria
You may qualify if your overweight and:
AND
Other criteria apply. A member of our team will check if this study is a good fit for you.
Locations
Overweight and obesity are complex, long-term health conditions that occur when excess body fat builds up and begins to affect overall health. They are commonly measured using body mass index (BMI). Many people living with excess weight may also develop type 2 diabetes, a condition where the body does not use insulin effectively, leading to high blood sugar levels.
Symptoms can include fatigue, shortness of breath, joint pain, low energy, and difficulty managing blood sugar. These conditions are increasingly common worldwide and can affect confidence, mobility, sleep, heart health, and overall quality of life.
Treatment for overweight, obesity, and type 2 diabetes often includes lifestyle changes such as improved nutrition, increased physical activity, behavioural support, and, in some cases, medication or surgery. While many people work hard to manage their health, long-term results can be challenging to maintain. Clinical research is helping to advance new treatment options, with studies aiming to improve effectiveness, safety and long-term help conditions.
This study is exploring an investigational medication for weight management for adults living with overweight or obesity, both with and without type 2 diabetes. Researchers are assessing safety, tolerability, weight reduction, and effects on metabolic health over time.
Participants will be randomly assigned to receive either the investigational treatment or a placebo (an inactive substance) taken as a once-daily oral tablet.
Throughout the study you will attend regular clinic visits for health assessments, which may include physical examinations, body weight measurements and general health checks. These visits help the research team monitor your health and collect important study information.
Your safety and wellbeing will be closely monitored by our professional clinical team for the duration of the study.
Why join a clinical research study?
Register your interest to find out if this study may be right for you. All information shared will be kept confidential.
Apply Now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research AU is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. By clicking 'Submit' you agree to our Privacy Policy which contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.